Three COVID-19 Vaccines OK For Pregnant / Breastfeeding!

Spread the love

Three COVID-19 vaccines are now approved for pregnant women and breastfeeding mothers in Malaysia!

Find out if you qualify, and how to register yourself for COVID-19 vaccination in Malaysia!

 

Three COVID-19 Vaccines OK For Pregnant / Breastfeeding!

On 25 June 2021, the Malaysia Ministry of Health (KKM) updated their guidelines for pregnant women and breastfeeding mothers.

Three COVID-19 vaccines – from Pfizer, Sinovac and AstraZeneca – have now been approved for use in pregnant women and breastfeeding mothers in Malaysia.

Under the National COVID-19 Vaccination Programme (PICK), all breastfeeding mothers and pregnant women between 14-33 weeks of pregnancy qualify for vaccination.

VaccinesPregnant
Women
Breastfeeding
Mothers
Pfizer14-33 weeks of pregnancyAll
AstraZeneca14-33 weeks of pregnancyAll
Sinovac14-33 weeks of pregnancyAll

Three COVID-19 Vaccines OK For Pregnant / Breastfeeding!

 

How To Register For COVID-19 Vaccine If Pregnant / Breastfeeding?

There are four ways for pregnant women and breastfeeding mothers to register for their free COVID-19 vaccination :

  1. The MySejahtera app – a future update will introduce a button to register for an appointment.
  2. The Vaksin COVID website.
  3. The telephone hotline : 1800-888-828
  4. Manually at health clinics, hospitals and private clinics

Here is our video guide on how to register yourself and/or your family for COVID-19 vaccination using the MySejahtera app.

It’s the same process, whether you are using an Apple iPhone, or an Android smartphone.

Don’t worry about making mistakes. You can redo the registration, to correct for mistakes.

For those who prefer a step-by-step, please see How To Register For COVID-19 Vaccination On MySejahtera!

 

Recommended Reading

Go Back To > Health | Tech ARP

 

Support Tech ARP!

If you like our work, please support us by visiting our sponsors, participating in the Tech ARP Forums, or even donating to our fund. Thank you!

About The Author

Leave a Reply